Litcius/Paper detail

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial

Emil Lou, Modassir S Choudhry, Timothy K. Starr, Timothy D. Folsom, Jason Bell, Blaine Rathmann, Anthony P. DeFeo, Ji‐Hyun Kim, Nicholas J. Slipek, Zhao-Hui Jin, Darin Sumstad, Christopher A. Klebanoff, Katherine J. Ladner, Akshat Sarkari, R. Scott McIvor, Thomas A. Murray, Jeffrey S. Miller, Madhuri Rao, Eric H. Jensen, Jacob S. Ankeny, Mahmoud A. Khalifa, Anil Chauhan, Benjamin Spilseth, Ajay Dixit, Paolo P. Provenzano, Wenjing Pan, Daniel Weber, Miranda Byrne‐Steele, Tom Henley, David H. McKenna, Matthew J. Johnson, Beau R. Webber, Branden S. Moriarity

2025The Lancet Oncology51 citationsDOI

Topics & Concepts

CRISPRColorectal cancerMedicineCISHImmune checkpointCancer researchImmune systemCancerOncologyBiologyInternal medicineImmunotherapyImmunologyGeneticsGeneGene expressionIn situ hybridizationCancer Immunotherapy and BiomarkersCAR-T cell therapy researchVirus-based gene therapy research